June 11, 2017
BONESUPPORT™ announces initial public offering on Nasdaq Stockholm and a related prospectus
Media
June 09, 2017
Nordic Nanovector to be included in Oslo Børs OBX Index
June 09, 2017
Targovax ASA – Information on the subsequent offering – Key date information
June 09, 2017
Wilson Therapeutics Receives US Orphan Drug Designation for WTX101 for the Treatment of ALS
June 08, 2017
TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
June 08, 2017
Wilson Therapeutics presents Phase 2 data for WTX101 at MDS meeting
June 07, 2017
Accepted abstract by ICML with updated results from Phase 1/2 trial of Betalutin® in NHL is now available on-line
June 07, 2017
Positive results from the CER-209 Phase I Single Dose Tolerance study for NAFLD and NASH
June 06, 2017
Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting
June 02, 2017
Nordic Nanovector to Present at Jefferies Healthcare Conference in New York on Thursday June 8th
